In the field of cancer medicine, the prevailing wisdom is that early detection and diagnosis saves lives. Catching cancer at earlier stages generally improves patient outcomes and increases chances of ...
Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...
A mathematical modeling study suggests that ovarian cancer incidence could be reduced and healthcare savings boosted if women who have already completed their families were offered fallopian tube ...
Ovarian cancer often starts in the fallopian tubes. That's why Mayo Clinic researchers started a living fallopian tube biobank — and it has already produced new scientific insights. Dr. Jamie ...
Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ...
Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...
Oncolytics Biotech ® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer ...
Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ...
The discovery that most ovarian cancers start, not in the ovaries, but the Fallopian tubes, means there may be a way to help prevent a disease that kills about 1000 women in Australia each year.
The removal of the fallopian tube while preserving the ovary, as demonstrated by gynecological surgeon Ingo Runnebaum using a model (GPI Anatomicals, USA), is a preventive measure against ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results